Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children

Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including Korea. In accordance with Korean regulations, we conducted a post-marketing surveillance (PMS) to evaluate the safety of DTaP-IPV...

Full description

Bibliographic Details
Main Authors: Soon Min Lee, Sung Jin Kim, Jing Chen, Rok Song, Joon-Hyung Kim, Raghavendra Devadiga, Yun-Kyung Kim
Format: Article
Language:English
Published: Taylor & Francis Group 2019-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
(5-10): dtap-ipv
post-marketing surveillance
safety
korea
diphtheria
tetanus
pertussis
poliomyelitis
Online Access:http://dx.doi.org/10.1080/21645515.2019.1572406

Internet

http://dx.doi.org/10.1080/21645515.2019.1572406

Similar Items